QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li 收藏  |  浏览/下载：30/0  |  提交时间：2022/12/22 Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022 作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge 收藏  |  浏览/下载：31/0  |  提交时间：2022/05/05 BRCA mutation  China  olaparib  ovarian cancer  PARP inhibitor   The choice of medical facility and associated factors among Chinese advanced colorectal cancer patients: a cross-sectional multi-center study 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2022 作者:  Wang, Xiao-Yang;  Wang, Wen-Jun;  Zhao, Yu-Qian;  Liu, Yin;  Wang, Xiao-Hui 收藏  |  浏览/下载：31/0  |  提交时间：2022/05/16 Colorectal cancer (CRC)  healthcare seeking  medical facility  associated factors